APO Research
Talk to an analyst

APO RESEARCH · REPORT

Terbinafine Hydrochloride Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Terbinafine Hydrochloride Drug Market Outlook and Growth Opportunities 2026

20 December 2025206 pages

Choose your research edition.

Industry ResearchTerbinafine Hydrochloride Drug Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Terbinafine Hydrochloride Drug Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Terbinafine Hydrochloride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Terbinafine Hydrochloride Drug Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Terbinafine Hydrochloride Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Terbinafine Hydrochloride Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Terbinafine Hydrochloride Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Terbinafine Hydrochloride Drug market include APOTEX, Breckenridge Pharmaceutical, CIPLA LTD, Cussess, Dr. Reddy's Laboratories, Glenmark, Harris Pharmaceutical, InvaGen Pharmaceuticals and Orchid Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Terbinafine Hydrochloride Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Terbinafine Hydrochloride Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Terbinafine Hydrochloride Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Terbinafine Hydrochloride Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Terbinafine Hydrochloride Drug Segment by Company

APOTEX

Breckenridge Pharmaceutical

CIPLA LTD

Cussess

Dr. Reddy's Laboratories

Glenmark

Harris Pharmaceutical

InvaGen Pharmaceuticals

Orchid Healthcare

TARO

GSK

Hubei Hengan Fulin Pharm

Jilin Wantong Group

Novartis

TEVA

Xiuzheng Pharmaceutical

Terbinafine Hydrochloride Drug Segment by Type

Topical

Oral

Terbinafine Hydrochloride Drug Segment by Application

Fingernail Infection

Toenail Infection

Others

Terbinafine Hydrochloride Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Terbinafine Hydrochloride Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Terbinafine Hydrochloride Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Terbinafine Hydrochloride Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Terbinafine Hydrochloride Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Terbinafine Hydrochloride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Terbinafine Hydrochloride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Terbinafine Hydrochloride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Terbinafine Hydrochloride Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Terbinafine Hydrochloride Drug industry.

Chapter 3: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Terbinafine Hydrochloride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Terbinafine Hydrochloride Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Terbinafine Hydrochloride Drug Industry Trends Table 2. Terbinafine Hydrochloride Drug Industry Drivers Table 3. Terbinafine Hydrochloride Drug Industry Opportunities and Challenges Table 4. Terbinafine Hydrochloride Drug Industry Restraints Table 5. Global Terbinafine Hydrochloride Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Terbinafine Hydrochloride Drug Revenue Share by Company (2021-2026) Table 7. Global Terbinafine Hydrochloride Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Terbinafine Hydrochloride Drug Sales Volume Share by Company (2021-2026) Table 9. Global Terbinafine Hydrochloride Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Terbinafine Hydrochloride Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Terbinafine Hydrochloride Drug Key Company Manufacturing Base & Headquarters Table 12. Global Terbinafine Hydrochloride Drug Company, Product Type & Application Table 13. Global Terbinafine Hydrochloride Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Terbinafine Hydrochloride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Topical Table 18. Significant Companies of Oral Table 19. Global Terbinafine Hydrochloride Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Terbinafine Hydrochloride Drug Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Terbinafine Hydrochloride Drug Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Terbinafine Hydrochloride Drug Sales Volume Share by Type (2021-2026) Table 23. Global Terbinafine Hydrochloride Drug Sales Volume Share by Type (2027-2032) Table 24. Global Terbinafine Hydrochloride Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Terbinafine Hydrochloride Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Terbinafine Hydrochloride Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Terbinafine Hydrochloride Drug Sales Value Share by Type (2021-2026) Table 28. Global Terbinafine Hydrochloride Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Fingernail Infection Table 30. Significant Companies of Toenail Infection Table 31. Significant Companies of Others Table 32. Global Terbinafine Hydrochloride Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Terbinafine Hydrochloride Drug Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Terbinafine Hydrochloride Drug Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Terbinafine Hydrochloride Drug Sales Volume Share by Application (2021-2026) Table 36. Global Terbinafine Hydrochloride Drug Sales Volume Share by Application (2027-2032) Table 37. Global Terbinafine Hydrochloride Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Terbinafine Hydrochloride Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Terbinafine Hydrochloride Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Terbinafine Hydrochloride Drug Sales Value Share by Application (2021-2026) Table 41. Global Terbinafine Hydrochloride Drug Sales Value Share by Application (2027-2032) Table 42. Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Terbinafine Hydrochloride Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2021-2026) Table 45. Global Terbinafine Hydrochloride Drug Sales by Region (2027-2032) & (W Units) Table 46. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2027-2032) Table 47. Global Terbinafine Hydrochloride Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Terbinafine Hydrochloride Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Terbinafine Hydrochloride Drug Sales Value Share by Region (2021-2026) Table 50. Global Terbinafine Hydrochloride Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Terbinafine Hydrochloride Drug Sales Value Share by Region (2027-2032) Table 52. Global Terbinafine Hydrochloride Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Terbinafine Hydrochloride Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Terbinafine Hydrochloride Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Terbinafine Hydrochloride Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 57. Global Terbinafine Hydrochloride Drug Sales Market Share by Country (2021-2026) Table 58. Global Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 59. Global Terbinafine Hydrochloride Drug Sales Market Share by Country (2027-2032) Table 60. Global Terbinafine Hydrochloride Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Terbinafine Hydrochloride Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Terbinafine Hydrochloride Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Terbinafine Hydrochloride Drug Sales Value Market Share by Country (2027-2032) Table 64. APOTEX Company Information Table 65. APOTEX Business Overview Table 66. APOTEX Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. APOTEX Terbinafine Hydrochloride Drug Product Portfolio Table 68. APOTEX Recent Development Table 69. Breckenridge Pharmaceutical Company Information Table 70. Breckenridge Pharmaceutical Business Overview Table 71. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 73. Breckenridge Pharmaceutical Recent Development Table 74. CIPLA LTD Company Information Table 75. CIPLA LTD Business Overview Table 76. CIPLA LTD Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio Table 78. CIPLA LTD Recent Development Table 79. Cussess Company Information Table 80. Cussess Business Overview Table 81. Cussess Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Cussess Terbinafine Hydrochloride Drug Product Portfolio Table 83. Cussess Recent Development Table 84. Dr. Reddy's Laboratories Company Information Table 85. Dr. Reddy's Laboratories Business Overview Table 86. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio Table 88. Dr. Reddy's Laboratories Recent Development Table 89. Glenmark Company Information Table 90. Glenmark Business Overview Table 91. Glenmark Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Glenmark Terbinafine Hydrochloride Drug Product Portfolio Table 93. Glenmark Recent Development Table 94. Harris Pharmaceutical Company Information Table 95. Harris Pharmaceutical Business Overview Table 96. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 98. Harris Pharmaceutical Recent Development Table 99. InvaGen Pharmaceuticals Company Information Table 100. InvaGen Pharmaceuticals Business Overview Table 101. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio Table 103. InvaGen Pharmaceuticals Recent Development Table 104. Orchid Healthcare Company Information Table 105. Orchid Healthcare Business Overview Table 106. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio Table 108. Orchid Healthcare Recent Development Table 109. TARO Company Information Table 110. TARO Business Overview Table 111. TARO Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. TARO Terbinafine Hydrochloride Drug Product Portfolio Table 113. TARO Recent Development Table 114. GSK Company Information Table 115. GSK Business Overview Table 116. GSK Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. GSK Terbinafine Hydrochloride Drug Product Portfolio Table 118. GSK Recent Development Table 119. Hubei Hengan Fulin Pharm Company Information Table 120. Hubei Hengan Fulin Pharm Business Overview Table 121. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio Table 123. Hubei Hengan Fulin Pharm Recent Development Table 124. Jilin Wantong Group Company Information Table 125. Jilin Wantong Group Business Overview Table 126. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio Table 128. Jilin Wantong Group Recent Development Table 129. Novartis Company Information Table 130. Novartis Business Overview Table 131. Novartis Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Novartis Terbinafine Hydrochloride Drug Product Portfolio Table 133. Novartis Recent Development Table 134. TEVA Company Information Table 135. TEVA Business Overview Table 136. TEVA Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. TEVA Terbinafine Hydrochloride Drug Product Portfolio Table 138. TEVA Recent Development Table 139. Xiuzheng Pharmaceutical Company Information Table 140. Xiuzheng Pharmaceutical Business Overview Table 141. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 143. Xiuzheng Pharmaceutical Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Terbinafine Hydrochloride Drug Distributors List Table 147. Terbinafine Hydrochloride Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Terbinafine Hydrochloride Drug Product Image Figure 2. Global Terbinafine Hydrochloride Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Terbinafine Hydrochloride Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Terbinafine Hydrochloride Drug Sales (2021-2032) & (W Units) Figure 5. Global Terbinafine Hydrochloride Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Terbinafine Hydrochloride Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Topical Image Figure 10. Oral Image Figure 11. Global Terbinafine Hydrochloride Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Terbinafine Hydrochloride Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Terbinafine Hydrochloride Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Terbinafine Hydrochloride Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Terbinafine Hydrochloride Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Terbinafine Hydrochloride Drug Sales Value Share by Type (2021-2032) Figure 17. Fingernail Infection Image Figure 18. Toenail Infection Image Figure 19. Others Image Figure 20. Global Terbinafine Hydrochloride Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Terbinafine Hydrochloride Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Terbinafine Hydrochloride Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Terbinafine Hydrochloride Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Terbinafine Hydrochloride Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Terbinafine Hydrochloride Drug Sales Value Share by Application (2021-2032) Figure 26. Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Terbinafine Hydrochloride Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Terbinafine Hydrochloride Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Terbinafine Hydrochloride Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Terbinafine Hydrochloride Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Terbinafine Hydrochloride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Terbinafine Hydrochloride Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Terbinafine Hydrochloride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Terbinafine Hydrochloride Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Terbinafine Hydrochloride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Terbinafine Hydrochloride Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Terbinafine Hydrochloride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Terbinafine Hydrochloride Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Terbinafine Hydrochloride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Terbinafine Hydrochloride Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Terbinafine Hydrochloride Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Topical
  • Oral
Applications
  • Fingernail Infection
  • Toenail Infection
  • Others
Companies covered
  • APOTEX
  • Breckenridge Pharmaceutical
  • CIPLA LTD
  • Cussess
  • Dr. Reddy's Laboratories
  • Glenmark
  • Harris Pharmaceutical
  • InvaGen Pharmaceuticals
  • Orchid Healthcare
  • TARO
  • GSK
  • Hubei Hengan Fulin Pharm
  • Jilin Wantong Group
  • Novartis
  • TEVA
  • Xiuzheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Terbinafine Hydrochloride Drug Sales Value (2021-2032)
  4. 1.2.2 Global Terbinafine Hydrochloride Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Terbinafine Hydrochloride Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Terbinafine Hydrochloride Drug Market Dynamics
  1. 2.1 Terbinafine Hydrochloride Drug Industry Trends
  2. 2.2 Terbinafine Hydrochloride Drug Industry Drivers
  3. 2.3 Terbinafine Hydrochloride Drug Industry Opportunities and Challenges
  4. 2.4 Terbinafine Hydrochloride Drug Industry Restraints
3 Terbinafine Hydrochloride Drug Market by Company
  1. 3.1 Global Terbinafine Hydrochloride Drug Company Revenue Ranking in 2025
  2. 3.2 Global Terbinafine Hydrochloride Drug Revenue by Company (2021-2026)
  3. 3.3 Global Terbinafine Hydrochloride Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Terbinafine Hydrochloride Drug Average Price by Company (2021-2026)
  5. 3.5 Global Terbinafine Hydrochloride Drug Company Ranking (2024-2026)
  6. 3.6 Global Terbinafine Hydrochloride Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Terbinafine Hydrochloride Drug Company Product Type and Application
  8. 3.8 Global Terbinafine Hydrochloride Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Terbinafine Hydrochloride Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Terbinafine Hydrochloride Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Terbinafine Hydrochloride Drug Market by Type
  1. 4.1 Terbinafine Hydrochloride Drug Type Introduction
  2. 4.1.1 Topical
  3. 4.1.2 Oral
  4. 4.2 Global Terbinafine Hydrochloride Drug Sales Volume by Type
  5. 4.2.1 Global Terbinafine Hydrochloride Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Terbinafine Hydrochloride Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Terbinafine Hydrochloride Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Terbinafine Hydrochloride Drug Sales Value by Type
  9. 4.3.1 Global Terbinafine Hydrochloride Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Terbinafine Hydrochloride Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Terbinafine Hydrochloride Drug Sales Value Share by Type (2021-2032)
5 Terbinafine Hydrochloride Drug Market by Application
  1. 5.1 Terbinafine Hydrochloride Drug Application Introduction
  2. 5.1.1 Fingernail Infection
  3. 5.1.2 Toenail Infection
  4. 5.1.3 Others
  5. 5.2 Global Terbinafine Hydrochloride Drug Sales Volume by Application
  6. 5.2.1 Global Terbinafine Hydrochloride Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Terbinafine Hydrochloride Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Terbinafine Hydrochloride Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Terbinafine Hydrochloride Drug Sales Value by Application
  10. 5.3.1 Global Terbinafine Hydrochloride Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Terbinafine Hydrochloride Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Terbinafine Hydrochloride Drug Sales Value Share by Application (2021-2032)
6 Terbinafine Hydrochloride Drug Regional Sales and Value Analysis
  1. 6.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Terbinafine Hydrochloride Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Terbinafine Hydrochloride Drug Sales by Region (2027-2032)
  5. 6.3 Global Terbinafine Hydrochloride Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Terbinafine Hydrochloride Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Terbinafine Hydrochloride Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Terbinafine Hydrochloride Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Terbinafine Hydrochloride Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Terbinafine Hydrochloride Drug Sales Value (2021-2032)
  12. 6.6.2 North America Terbinafine Hydrochloride Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Terbinafine Hydrochloride Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Terbinafine Hydrochloride Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Terbinafine Hydrochloride Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Terbinafine Hydrochloride Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Terbinafine Hydrochloride Drug Sales Value (2021-2032)
  21. 6.9.2 South America Terbinafine Hydrochloride Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Terbinafine Hydrochloride Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Terbinafine Hydrochloride Drug Sales Value Share by Country, 2025 VS 2032
7 Terbinafine Hydrochloride Drug Country-level Sales and Value Analysis
  1. 7.1 Global Terbinafine Hydrochloride Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Terbinafine Hydrochloride Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Terbinafine Hydrochloride Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Terbinafine Hydrochloride Drug Sales by Country (2027-2032)
  6. 7.4 Global Terbinafine Hydrochloride Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Terbinafine Hydrochloride Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Terbinafine Hydrochloride Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Terbinafine Hydrochloride Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Terbinafine Hydrochloride Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Terbinafine Hydrochloride Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 APOTEX
  2. 8.1.1 APOTEX Company Information
  3. 8.1.2 APOTEX Business Overview
  4. 8.1.3 APOTEX Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
  6. 8.1.5 APOTEX Recent Developments
  7. 8.2 Breckenridge Pharmaceutical
  8. 8.2.1 Breckenridge Pharmaceutical Company Information
  9. 8.2.2 Breckenridge Pharmaceutical Business Overview
  10. 8.2.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  12. 8.2.5 Breckenridge Pharmaceutical Recent Developments
  13. 8.3 CIPLA LTD
  14. 8.3.1 CIPLA LTD Company Information
  15. 8.3.2 CIPLA LTD Business Overview
  16. 8.3.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
  18. 8.3.5 CIPLA LTD Recent Developments
  19. 8.4 Cussess
  20. 8.4.1 Cussess Company Information
  21. 8.4.2 Cussess Business Overview
  22. 8.4.3 Cussess Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
  24. 8.4.5 Cussess Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Glenmark
  32. 8.6.1 Glenmark Company Information
  33. 8.6.2 Glenmark Business Overview
  34. 8.6.3 Glenmark Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
  36. 8.6.5 Glenmark Recent Developments
  37. 8.7 Harris Pharmaceutical
  38. 8.7.1 Harris Pharmaceutical Company Information
  39. 8.7.2 Harris Pharmaceutical Business Overview
  40. 8.7.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  42. 8.7.5 Harris Pharmaceutical Recent Developments
  43. 8.8 InvaGen Pharmaceuticals
  44. 8.8.1 InvaGen Pharmaceuticals Company Information
  45. 8.8.2 InvaGen Pharmaceuticals Business Overview
  46. 8.8.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
  48. 8.8.5 InvaGen Pharmaceuticals Recent Developments
  49. 8.9 Orchid Healthcare
  50. 8.9.1 Orchid Healthcare Company Information
  51. 8.9.2 Orchid Healthcare Business Overview
  52. 8.9.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
  54. 8.9.5 Orchid Healthcare Recent Developments
  55. 8.10 TARO
  56. 8.10.1 TARO Company Information
  57. 8.10.2 TARO Business Overview
  58. 8.10.3 TARO Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
  60. 8.10.5 TARO Recent Developments
  61. 8.11 GSK
  62. 8.11.1 GSK Company Information
  63. 8.11.2 GSK Business Overview
  64. 8.11.3 GSK Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
  66. 8.11.5 GSK Recent Developments
  67. 8.12 Hubei Hengan Fulin Pharm
  68. 8.12.1 Hubei Hengan Fulin Pharm Company Information
  69. 8.12.2 Hubei Hengan Fulin Pharm Business Overview
  70. 8.12.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
  72. 8.12.5 Hubei Hengan Fulin Pharm Recent Developments
  73. 8.13 Jilin Wantong Group
  74. 8.13.1 Jilin Wantong Group Company Information
  75. 8.13.2 Jilin Wantong Group Business Overview
  76. 8.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
  78. 8.13.5 Jilin Wantong Group Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 TEVA
  86. 8.15.1 TEVA Company Information
  87. 8.15.2 TEVA Business Overview
  88. 8.15.3 TEVA Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
  90. 8.15.5 TEVA Recent Developments
  91. 8.16 Xiuzheng Pharmaceutical
  92. 8.16.1 Xiuzheng Pharmaceutical Company Information
  93. 8.16.2 Xiuzheng Pharmaceutical Business Overview
  94. 8.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  96. 8.16.5 Xiuzheng Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Terbinafine Hydrochloride Drug Value Chain Analysis
  2. 9.1.1 Terbinafine Hydrochloride Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Terbinafine Hydrochloride Drug Sales Mode & Process
  6. 9.2 Terbinafine Hydrochloride Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Terbinafine Hydrochloride Drug Distributors
  9. 9.2.3 Terbinafine Hydrochloride Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst